This may be due to the fact that the quercetin binds to either the COVID-19 spike protein at its host receptor region or the spike protein of the human angiotensin-converting enzyme 2 (ACE2) receptor interface, inhibiting the virus entry to cells and disrupting host–virus interactions indicating its therapeutic potential (Smith and Smith 2020). The gene discussed is ACE2; the disease is COVID-19.